Real-world outcomes of patients with advanced-stage hepatocellular carcinoma receiving combination therapy with atezolizumab and bevacizumab: A South Australian statewide experience

被引：0
|
作者：
Chan, A. [1 ,2 ]
Saluja, H. [1 ]
Nind, G. [3 ]
Singhal, N. [1 ]
Roy, A. [4 ]
Mcgregor, M. [2 ]
Chinnaratha, A. [2 ]
机构：
[1] Royal Adelaide Hosp, Adelaide, SA, Australia
[2] Lyell McEwin Hosp, Adelaide, SA, Australia
[3] Queen Elizabeth Hosp, Adelaide, SA, Australia
[4] Flinders Med Ctr, Adelaide, SA, Australia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
118
引用
收藏
页码：56 / 57
页数：2
相关论文
共 50 条
  • [1] Real-world experience of atezolizumab/bevacizumab in hepatocellular carcinoma
    Ha, Yeonjung
    Cheon, Jaekyung
    Hwang, Seong Gyu
    Chon, Hong Jae
    JOURNAL OF HEPATOLOGY, 2021, 75 : S526 - S527
  • [2] Real-world experience of atezolizumab plus bevacizumab combination treatment in high risk patients with advanced hepatocellular carcinoma
    Hwang, Sangyoun
    Woo, Hyun Young
    Heo, Jeong
    Kim, Hyung Jun
    Park, Young Joo
    Yi, Kiyoun
    Lee, Yu Rim
    Park, Soo Young
    Jang, Byoung Kuk
    Chung, Woo Jin
    Tak, Won Young
    JOURNAL OF HEPATOLOGY, 2023, 78 : S588 - S588
  • [3] REAL-WORLD EXPERIENCE OF ATEZOLIZUMAB PLUS BEVACIZUMAB COMBINATION TREATMENT IN HIGH-RISK PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA
    Woo, Hyun Young
    Hwang, Sangyoun
    Heo, Jeong
    Kim, Hyung Jun
    Park, Young Joo
    Yi, Ki Youn
    Lee, Yu Rim
    Park, Soo Young
    Chung, Woo Jin
    Jang, Byoung-Kuk
    Tak, Won Young
    HEPATOLOGY, 2023, 78 : S1880 - S1881
  • [4] Atezolizumab and bevacizumab in patients with advanced hepatocellular carcinoma with impaired liver function and prior systemic therapy: a real-world experience
    de Castro, Tiago
    Jochheim, Leonie S.
    Bathon, Melanie
    Welland, Sabrina
    Scheiner, Bernhard
    Shmanko, Kateryna
    Roessler, Daniel
    Ben Khaled, Najib
    Jeschke, Matthias
    Ludwig, Johannes M.
    Marquardt, Jens U.
    Weinmann, Arndt
    Pinter, Matthias
    Lange, Christian M.
    Vogel, Arndt
    Saborowski, Anna
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [5] Atezolizumab and bevacizumab in advanced hepatocellular carcinoma: Real-world data.
    Bezalel, Nomi
    Davidov, Yana
    Likhter, Mariya
    Ezra, Oranit Cohen
    Inbar, Yael
    Halpern, Naama
    Ben Boursi
    Beller, Tamar
    Pery, Ron
    Shmueli, Einat S.
    Nachmany, Ido
    Ben Ari, Ziv
    Margalit, Ofer
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [6] Real-world experience of atezolizumab and bevacizumab for treatment of advanced hepatocellular carcinoma in a single tertiary center
    Raharjo, C. V.
    Joseph, R.
    Stratton, E.
    Levy, M.
    Prakoso, E.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 22 - 22
  • [7] Atezolizumab and bevacizumab for advanced hepatocellular carcinoma: a single centre real world experience
    Tan, Pei Ying
    Hui, Samuel
    O'Neill, Paul
    Dev, Anouk
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 : 142 - 143
  • [8] Early experience of atezolizumab plus bevacizumab therapy in Japanese patients with unresectable hepatocellular carcinoma in real-world practice
    Yuka Hayakawa
    Kaoru Tsuchiya
    Masayuki Kurosaki
    Yutaka Yasui
    Shun Kaneko
    Yuki Tanaka
    Shun Ishido
    Kento Inada
    Sakura Kirino
    Koji Yamashita
    Tsubasa Nobusawa
    Hiroaki Matsumoto
    Tatsuya Kakegawa
    Mayu Higuchi
    Kenta Takaura
    Shohei Tanaka
    Chiaki Maeyashiki
    Nobuharu Tamaki
    Hiroyuki Nakanishi
    Jun Itakura
    Yuka Takahashi
    Yasuhiro Asahina
    Ryuichi Okamoto
    Namiki Izumi
    Investigational New Drugs, 2022, 40 : 392 - 402
  • [9] Early experience of atezolizumab plus bevacizumab therapy in Japanese patients with unresectable hepatocellular carcinoma in real-world practice
    Hayakawa, Yuka
    Tsuchiya, Kaoru
    Kurosaki, Masayuki
    Yasui, Yutaka
    Kaneko, Shun
    Tanaka, Yuki
    Ishido, Shun
    Inada, Kento
    Kirino, Sakura
    Yamashita, Koji
    Nobusawa, Tsubasa
    Matsumoto, Hiroaki
    Kakegawa, Tatsuya
    Higuchi, Mayu
    Takaura, Kenta
    Tanaka, Shohei
    Maeyashiki, Chiaki
    Tamaki, Nobuharu
    Nakanishi, Hiroyuki
    Itakura, Jun
    Takahashi, Yuka
    Asahina, Yasuhiro
    Okamoto, Ryuichi
    Izumi, Namiki
    INVESTIGATIONAL NEW DRUGS, 2022, 40 (02) : 392 - 402
  • [10] ANALYSIS OF FACTORS PREDICTING THE REAL-WORLD EFFICACY OF ATEZOLIZUMAB AND BEVACIZUMAB IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA
    Ha, Chang Won
    Paik, Yong-Han
    Song, Byeong Geun
    HEPATOLOGY, 2024, 80
12345